Biotech group Chi-Med plans Hong Kong listing of up to $500 mln - sources
April 15, 2019 at 09:36 AM EDT
Biotech company Hutchison China MediTech, known as Chi-Med, has filed for a Hong Kong listing, which four sources close to the matter said could raise up to $500 million.
